Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8751
Century Therapeutics
IPSC
$366M
| $675K | ﹤0.01% |
+23,001
| New | +$584K |
|
8752
CALL
Ashland
ASH
$3.41B
| $674K | ﹤0.01% |
7,700
-36,400
| -83% | -$3.28M |
|
8753
PUT
VanEck Social Sentiment ETF
BUZZ
$112M
| $674K | ﹤0.01% |
25,200
-10,300
| -29% | -$255K |
|
8754
CALL
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
| $674K | ﹤0.01% |
11,200
+2,800
| +33% | +$167K |
|
8755
Nuvation Bio
NUVB
$2.34B
| $674K | ﹤0.01% |
72,425
+39,287
| +119% | +$448K |
|
8756
ProShares UltraPro Short S&P 500
SPXU
$387M
| $674K | ﹤0.01% |
1,851
-8,080
| -81% | -$3.24M |
|
|
CLDT
8757
CALL
Chatham Lodging
CLDT
$637M
| $673K | ﹤0.01% |
52,300
+3,800
| +8% | +$50.7K |
|
8758
PUT
HUB Group
HUBG
$2.42B
| $673K | ﹤0.01% |
+20,400
| New | +$695K |
|
8759
CALL
Kirby Corp
KEX
$7.34B
| $673K | ﹤0.01% |
11,100
-47,300
| -81% | -$3.05M |
|
8760
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.55M
| $673K | ﹤0.01% |
+9,500
| New | +$667K |
|
8761
PUT
Cimpress
CMPR
$2.17B
| $672K | ﹤0.01% |
6,200
+1,100
| +22% | +$111K |
|
8762
PUT
Innoviva
INVA
$1.51B
| $672K | ﹤0.01% |
50,100
-48,200
| -49% | -$603K |
|
8763
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.24B
| $672K | ﹤0.01% |
+2,540
| New | +$610K |
|
|
TRTX
8764
TPG RE Finance Trust
TRTX
$593M
| $672K | ﹤0.01% |
49,963
+19,842
| +66% | +$254K |
|
|
VER
8765
DELISTED
VEREIT, Inc.
VER
| $672K | ﹤0.01% |
14,631
-47,481
| -76% | -$2.15M |
|
|
ASHX
8766
DELISTED
Xtrackers MSCI China A Inclusion Equity ETF
ASHX
| $672K | ﹤0.01% |
21,795
+1
| +0% | +$30 |
|
8767
PUT
Global X Cloud Computing ETF
CLOU
$383M
| $671K | ﹤0.01% |
23,500
-196,300
| -89% | -$5.25M |
|
8768
CVB Financial
CVBF
$3.91B
| $671K | ﹤0.01% |
32,570
-131
| -0.4% | -$2.86K |
|
|
CKPT
8769
DELISTED
Checkpoint Therapeutics
CKPT
| $670K | ﹤0.01% |
+22,728
| New | +$630K |
|
8770
First Trust Germany AlphaDEX Fund
FGM
$99.9M
| $670K | ﹤0.01% |
11,754
-9,047
| -43% | -$519K |
|
8771
iShares Russell 1000 Value ETF
IWD
$84.3B
| $670K | ﹤0.01% |
+4,225
| New | +$669K |
|
8772
Lufax Holding
LU
$1.14B
| $670K | ﹤0.01% |
14,826
-43,042
| -74% | -$2.17M |
|
8773
iShares Russell 2500 ETF
SMMD
$3.78B
| $670K | ﹤0.01% |
10,112
-30,984
| -75% | -$2.02M |
|
8774
Axos Financial
AX
$5.55B
| $669K | ﹤0.01% |
14,426
+4,635
| +47% | +$217K |
|
8775
International Bancshares
IBOC
$4.41B
| $669K | ﹤0.01% |
15,585
-7,565
| -33% | -$353K |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.